1. Home
  2. BFS vs EVO Comparison

BFS vs EVO Comparison

Compare BFS & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BFS

Saul Centers Inc.

HOLD

Current Price

$33.67

Market Cap

809.1M

Sector

Real Estate

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.73

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFS
EVO
Founded
1993
1993
Country
United States
Germany
Employees
98
4553
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
809.1M
934.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BFS
EVO
Price
$33.67
$2.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$44.00
$7.00
AVG Volume (30 Days)
40.5K
95.9K
Earning Date
05-11-2026
04-08-2026
Dividend Yield
6.92%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$0.30
$1.37
Revenue Next Year
$5.67
$10.05
P/E Ratio
$30.48
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.16
$2.31
52 Week High
$35.45
$4.80

Technical Indicators

Market Signals
Indicator
BFS
EVO
Relative Strength Index (RSI) 44.32 41.07
Support Level $33.14 $2.32
Resistance Level $34.99 $3.78
Average True Range (ATR) 0.81 0.09
MACD -0.15 -0.06
Stochastic Oscillator 30.82 19.16

Price Performance

Historical Comparison
BFS
EVO

About BFS Saul Centers Inc.

Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: Shopping Centers segment, which contribute the maximum portion of total revenue; and mixed-use properties.Mixed-Use Properties segment include office, retail and multi-family residential use.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: